Analyst expectations for where Amazon stock is headed vary, but Wall Street remains optimistic overall, especially in the ...

He talks with his hands and emphasizes his points with catchphrases such as “How about no” or “How about we don’t.” Lutnick ...

A standoff over Elevidys could have major consequences for Duchenne patients, gene therapy companies and the perception of ...

Investing.com -- Sarepta Therapeutics Inc (NASDAQ: SRPT) stock tumbled 10% following the announcement that the U.S. Food and Drug Administration has placed a clinical hold on the company’s ...

Shares of Elevance Health Inc. (NYSE:ELV) dropped to a new 52-week low of $275.60, reflecting a turbulent year for the ...

Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) plunged 10% after the company disclosed that the U.S. Food and Drug ...

The Trump administration’s decision to stop sharing military satellite information with meteorologists will accelerate the ...

Evercore ISI Group analyst Mark Lipacis maintained an Outperform rating and increased the price target from $237 to $289 on ...

India's markets regulator has allowed Jane Street to restart trading after the U.S. high-frequency trading firm deposited ...

Investment bank Canaccord Genuity has reportedly suspended research coverage of 15 cannabis companies following an analyst departure. The suspension affects major Canadian cannabis producers, ...

Leerink Partnrs has trimmed its Q2 2025 earnings estimate for Merck & Co., Inc., foreseeing a dip to $1.96 per share from ...